AORT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Artivion Inc (AORT) is not a strong buy for a beginner, long-term investor at this time. The company's recent financial performance shows declining net income and EPS, and the stock's technical indicators and trading trends do not suggest a clear upward momentum. While analysts have given a Buy rating with a price target of $42, the lack of significant positive catalysts and the current price trend make it prudent to hold off on investing until stronger signals emerge.
The MACD is above zero but positively contracting, indicating weakening momentum. RSI is neutral at 49.951, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 36.111, with resistance at 38.527 and support at 33.695. Overall, the technical indicators do not show a strong bullish signal.
Analyst Jeffrey Cohen upgraded the stock to Buy with a $42 price target. The company reported 19.20% YoY revenue growth in Q4 2025.
The company faces challenges with limited distribution channels and lack of free cash flow, hindering reinvestment. The stock has a 40% chance of declining by -5.54% over the next month.
In Q4 2025, revenue increased by 19.20% YoY to $115.99M, but net income dropped to $2.42M (-114.73% YoY), and EPS fell to $0.05 (-112.82% YoY). Gross margin slightly decreased to 63.06% (-0.22% YoY).
Analysts are generally positive on the stock. Jeffrey Cohen upgraded it to Buy with a $42 price target, while William Plovanic maintained a Buy rating but reduced the price target to $48 from $51, citing strong Q4 performance despite one-time revenue reductions.
